Inflammatory Cytokines Stimulate Bone Morphogenetic Protein-2 Expression and Release from Pancreatic Beta Cells

Journal of Interferon and Cytokine Research

Volumn 36, Issue 1, 2016, Pages 20-29

  Ibarra Urizar, Adriana ^a   Friberg, Josefine ^a   Christensen, Dan Ploug ^a   Lund Christensen, Gitte ^a   Billestrup, Nils ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ALK 3 FC PROTEIN; BETA INTERFERON; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 4; GAMMA INTERFERON; HYBRID PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INHIBITOR OF DIFFERENTIATION 1; INHIBITOR OF DIFFERENTIATION 2; INHIBITOR OF DIFFERENTIATION 4; INHIBITOR OF DIFFERENTIATION PROTEIN; INTERLEUKIN 1BETA; MESSENGER RNA; RNA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; BMP2 PROTEIN, RAT; IL1B PROTEIN, RAT; PROTEIN BINDING;

ANIMAL CELL; APOPTOSIS; ARTICLE; BINDING SITE; CELL GROWTH; CELL STIMULATION; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; GEL MOBILITY SHIFT ASSAY; HUMAN; HUMAN CELL; NEWBORN; NONHUMAN; PANCREAS ISLET; PANCREAS ISLET BETA CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN SECRETION; QUANTITATIVE ANALYSIS; RAT; REAL TIME POLYMERASE CHAIN REACTION; RNA EXTRACTION; UPREGULATION; ADULT; ANIMAL; CELL LINE; CYTOLOGY; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MIDDLE AGED; SIGNAL TRANSDUCTION; TISSUE CULTURE TECHNIQUE; WISTAR RAT;

ADULT; ANIMALS; ANIMALS, NEWBORN; BINDING SITES; BONE MORPHOGENETIC PROTEIN 2; CELL LINE; GENE EXPRESSION REGULATION; HUMANS; INSULIN-SECRETING CELLS; INTERFERON-GAMMA; INTERLEUKIN-1BETA; MIDDLE AGED; NF-KAPPA B; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; RATS; RATS, WISTAR; RNA, MESSENGER; SIGNAL TRANSDUCTION; TISSUE CULTURE TECHNIQUES;

EID: 84954450114     PISSN: 10799907     EISSN: 15577465     Source Type: Journal    
DOI: 10.1089/jir.2014.0199     Document Type: Article

References (37)

1. Ahnfelt-Rønne J, Ravassard P, Pardanaud-Glavieux C, Scharfmann R, Serup P. 2010. Mesenchymal bone morphogenetic protein signaling is required for normal pancreas development. Diabetes 59:1948-1956.
2. Akerfeldt MC, Laybutt DR. 2011. Inhibition of Id1 augments insulin secretion and protects against high-fat diet-induced glucose intolerance. Diabetes 60:2506-2514.
3. Böni-Schnetzler M, Boller S, Debray S, Bouzakri K, Meier DT, Prazak R, Kerr-Conte J, Pattou F, Ehses JA, Schuit FC, Donath MY. 2009. Free fatty acids induce a proinflammatory response in islets via the abundantly expressed interleukin-1 receptor I. Endocrinology 150:5218-5229.
4. Boström KI, Jumabay M, Matveyenko A, Nicholas SB, Yao Y. 2010. Activation of vascular bone morphogenetic protein signaling in diabetes mellitus. Circ Res 108(4):446-457.
5. Böttcher Y, Unbehauen H, Klöting N, Ruschke K, Körner A, Schleinitz D, Tönjes A, Enigk B, Wolf S, Dietrich K, Koriath M, Scholz GH, Tseng Y-H, Dietrich A, Schön MR, Kiess W, Stumvoll M, Blüher M, Kovacs P. 2009. Adipose tissue expression and genetic variants of the bone morphogenetic protein receptor 1A gene (BMPR1A) are associated with human obesity. Diabetes 58:2119-2128.
6. Bruun C, Christensen GL, Jacobsen MLB, Kanstrup MB, Jensen PR, Fjordvang H, Mandrup-Poulsen T, Billestrup N. 2014. Inhibition of beta cell growth and function by bone morphogenetic proteins. Diabetologia 57(12):2546-2554.
7. Christensen DP, Gysemans C, Lundh M, Dahllö f MS, Noesgaard D, Schmidt SF, Mandrup S, Birkbak N, Workman CT, Piemonti L, Blaabjerg L, Monzani V, Fossati G, Mascagni P, Paraskevas S, Aikin RA, Billestrup N, Grunnet LG, Dinarello CA, Mathieu C, Mandrup-Poulsen T. 2014. Lysine deacetylase inhibition prevents diabetes by chromatin-independent immunoregulation and b-cell protection. Proc Natl Acad Sci U S A 111:1055-1059.
8. Chung W-S, Shin CH, Stainier DYR. 2008. Bmp2 signaling regulates the hepatic vs pancreatic fate decision. Dev Cell 15:738-748.
9. Csiszar A, Ahmad M, Smith K, ELabinskyy N, Gao Q, Kaley G, Edwards JG, Wolin MS, Ungvari Z. 2006. Bone morphogenetic protein-2 induces proinflammatory endothelial phenotype. Am J Pathol 168:629-638.
10. Donath MY, Shoelson SE. 2011. Type 2 diabetes as an inflammatory disease. Nat Rev Immunol 11:98-107.
11. Ehses JA, Perren A, Eppler E, Ribaux P, Pospisilik JA, Maor-Cahn R, Gueripel X, Ellingsgaard H, Schneider MKJ, Biollaz G, Fontana A, Reinecke M, Homo-Delarche F, Donath MY. 2007. Increased number of islet-associated macrophages in type 2 diabetes. Diabetes 56:2356-2370.
12. Eizirik DL, Colli ML, Ortis F. 2009. The role of inflammation in insulitis and beta-cell loss in type 1 diabetes. Nat Rev Endocrinol 5:219-226.
13. Eizirik DL, Mandrup-Poulsen T. 2001. A choice of death-the signal-transduction of immune-mediated beta-cell apoptosis. Diabetologia 44:2115-2133.
14. Eizirik DL, Sammeth M, Bouckenooghe T, Bottu G, Sisino G, Igoillo-Esteve M, Ortis F, Santin I, Colli ML, Barthson J, Bouwens L, Hughes L, Gregory L, Lunter G, Marselli L, Marchetti P, McCarthy MI, Cnop M. 2012. The human pancreatic islet transcriptome: expression of candidate genes for type 1 diabetes and the impact of pro-inflammatory cytokines. PLoS Genet 8:e1002552.
15. Fadista J, Vikman P, Laakso EO, Mollet IG, Esguerra JL, Taneera J, Storm P, Osmark P, Ladenvall C, Prasad RB, Hansson KB, Finotello F, Uvebrant K, Ofori JK, Di Camillo B, Krus U, Cilio CM, Hansson O, Eliasson L, Rosengren AH, Renström E, Wollheim CB, Groop L. 2014. Global genomic and transcriptomic analysis of human pancreatic islets reveals novel genes influencing glucose metabolism. Proc Natl Acad Sci U S A 111:13924-13929.
16. Feng JQ, Harris MA, Ghosh-Choudhury N, Feng M, Mundy GR, Harris SE. 1994. Structure and sequence of mouse bone morphogenetic protein-2 gene (BMP-2): comparison of the structures and promoter regions of BMP-2 and BMP-4 genes. Biochim Biophys Acta 1218:221-224.
17. Feng JQ, Xing L, Zhang J-H, Zhao M, Horn D, Chan J, Boyce BF, Harris SE, Mundy GR, Chen D. 2003. NF-kappaB specifically activates BMP-2 gene expression in growth plate chondrocytes in vivo and in a chondrocyte cell line in vitro. J Biol Chem 278:29130-29135.
18. Fukui N, Zhu Y, Maloney WJ, Clohisy J, Sandell LJ. 2003. Stimulation of BMP-2 expression by pro-inflammatory cytokines IL-1 and TNF-alpha in normal and osteoarthritic chondrocytes. J Bone Joint Surg Am 85-A (Suppl. 3): 59-66.
19. Ghil S-H, Jeon Y-J, Suh-Kim H. 2002. Inhibition of BETA2/ NeuroD by Id2. Exp Mol Med 34:367-373.
20. Goulley J, Dahl U, Baeza N, Mishina Y, Edlund H. 2007. BMP4-BMPR1A signaling in beta cells is required for and augments glucose-stimulated insulin secretion. Cell Metab 5:207-219.
21. Gradwohl G, Dierich A, LeMeur M, Guillemot F. 2000. neurogenin3 is required for the development of the four endocrine cell lineages of the pancreas. Proc Natl Acad Sci U S A 97:1607-1611.
22. Helvering LM, Sharp RL, Ou X, Geiser AG. 2000. Regulation of the promoters for the human bone morphogenetic protein 2 and 4 genes. Gene 256:123-138.
23. Hua H, Zhang Y-Q, Dabernat S, Kritzik M, Dietz D, Sterling L, Sarvetnick N. 2006. BMP4 regulates pancreatic progenitor cell expansion through Id2. J Biol Chem 281:13574-13580.
24. Jiang S, Chandler RL, Fritz DT, Mortlock DP, Rogers MB. 2010. Repressive BMP2 gene regulatory elements near the BMP2 promoter. Biochem Biophys Res Commun 392:124-128.
25. Koga M, Engberding N, Dikalova AE, Chang KH, Seidel-Rogol B, Long JS, Lassegue B, Jo H, Griendling KK. 2013. The bone morphogenic protein inhibitor, noggin, reduces glycemia and vascular inflammation in db/db mice. AJP Heart Circ Physiol 305:H747-H755.
26. Larsen CM, Faulenbach M, Vaag A, Vølund A, Ehses JA, Seifert B, Mandrup-Poulsen T, Donath MY. 2007. Interleukin-1-receptor antagonist in type 2 diabetes mellitus. N Engl J Med 356:1517-1526.
27. Lories RJU, Derese I, Ceuppens JL, Luyten FP. 2003. Bone morphogenetic proteins 2 and 6, expressed in arthritic synovium, are regulated by proinflammatory cytokines and differentially modulate fibroblast-like synoviocyte apoptosis. Arthritis Rheum 48:2807-2818.
28. Maedler K, Sergeev P, Ris F, Oberholzer J, Joller-Jemelka HI, Spinas GA, Kaiser N, Halban PA, Donath MY. 2002. Glucose-induced beta-cell production of IL-1beta contributes to glucotoxicity in human pancreatic islets. J Clin Invest 110:851-860.
29. Mandrup-Poulsen DT. 1996. The role of interleukin-1 in the pathogenesis of IDDM. Diabetologia 39:1005-1029.
30. Naya FJ, Huang HP, Qiu Y, Mutoh H, DeMayo FJ, Leiter AB, Tsai MJ. 1997. Diabetes, defective pancreatic morphogenesis, and abnormal enteroendocrine differentiation in BETA2/ neuroD-deficient mice. Genes Dev 11:2323-2334.
31. O'Neill LA. 2000. The interleukin-1 receptor/Toll-like receptor superfamily: signal transduction during inflammation and host defense. Sci STKE 2000:re1.
32. Richardson SJ, Willcox A, Bone AJ, Foulis AK, Morgan NG. 2009. Islet-associated macrophages in type 2 diabetes. Diabetologia 52:1686-1688.
33. Rønn SG, Hansen JA, Lindberg K, Karlsen AE, Billestrup N. 2002. The effect of suppressor of cytokine signaling 3 on GH signaling in B-cells. Mol Endocrinol 16:2124-2134.
34. Scott GJ, Ray MK, Ward T, McCann K, Peddada S, Jiang F-X, Mishina Y. 2009. Abnormal glucose metabolism in heterozygous mutant mice for a type I receptor required for BMP signaling. Genesis 47:385-391.
35. Son J-W, Kim M-K, Park Y-M, Baek K-H, Yoo S-J, Song K-H, Son HS, Yoon K-H, Lee, WC, Cha B-Y, Son H-Y, Kwon, HS. 2011. Association of serum bone morphogenetic protein 4 levels with obesity and metabolic syndrome in non-diabetic individuals. Endocr J 58:39-46.
36. Wagner DO, Sieber C, Bhushan R, Börgermann JH, Graf D, Knaus P. 2010. BMPs: from bone to body morphogenetic proteins. Sci Signal 3:mr1.
37. Wellen KE, Hotamisligil GS. 2005. Inflammation, stress, and diabetes. J Clin Invest 115:1111-1119.